Duration: 1:15:05 | 27 May 2015
Prof Ed Bullmore
In this talk, Prof Ed Bullmore discussed recent progress in the new science of neuro-immunology that has shown that the brain is intimately interconnected with the immune system. This creates an opportunity for radically new ways of understanding mental health disorders and their treatment. The Medical Research Council and the Wellcome Trust have recently invested, with major pharmaceutical companies, in two consortia set up to explore specifically the rationale for anti-inflammatory drugs as new treatments for some (inflamed) patients with depression.
About the speaker
Since 2013, Prof Bullmore has been Vice-President, ImmunoPsychiatry at GlaxoSmithKline. He is Clinical Director of the Wellcome Trust/MRC funded Behavioural & Clinical Neuroscience Institute, Scientific Director of the Wolfson Brain Imaging Centre, Chair of Cambridge Health Imaging, Co-Chair of Cambridge Neuroscience, and Head of the Department of Psychiatry, at the University of Cambridge; and an honorary Consultant Psychiatrist and Director of R&D in Cambridgeshire & Peterborough Foundation NHS Trust.
He has published about 450 scientific papers and his work has been highly cited. He has been elected as a Fellow of the Royal College of Physicians, the Royal College of Psychiatrists, and the Academy of Medical Sciences. His research has focused on mathematical analysis of neuroimaging data, applications of neuroimaging to understanding of neuropsychiatric disorders, and development of new therapeutic approaches for mental health disorders.
Read more about Prof Ed Bullmore